<DOC>
	<DOCNO>NCT00610350</DOCNO>
	<brief_summary>The aim study investigate whether pharmacological pre-treatment levosimendan reduces intensive care unit ( ICU ) length stay patient undergo elective myocardial revascularization cardiopulmonary bypass .</brief_summary>
	<brief_title>Levosimendan Myocardial Protection</brief_title>
	<detailed_description />
	<mesh_term>Simendan</mesh_term>
	<criteria>age â‰¥18 year intention perform firsttime multivessel CABG unstable angina valvular disease diabetes mellitus treat sulphonylurea drug renal failure severe hepatic disease severe chronic obstructive pulmonary disease history prior CABG surgery recent myocardial infarction ( MI ) within previous month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Levosimendan</keyword>
	<keyword>pre-conditioning</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>myocardial function</keyword>
	<keyword>contractility</keyword>
	<keyword>heart</keyword>
	<keyword>ischaemia</keyword>
</DOC>